Search
for
Sort by
Research 361–390 of 1000+
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation
- Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- Sox9 expression in canine epithelial skin tumors
- African Journal of Biomedical Research
- Skin health of community-living older people: a scoping review
- Warty Dyskeratoma Involving Two Adjoining Follicles
- Other Questions on Basaloid Follicular Hamartoma
- Cutaneous Granular Cell Tumor with Overlying Hypertrichosis in an Adult: A Rare Case Report
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Inactivation of the Vitamin D Receptor Enhances Susceptibility of Murine Skin to UV-Induced Tumorigenesis
- CD34 Expression by Hair Follicle Stem Cells Is Required for Skin Tumor Development in Mice
- Genetic architecture of mouse skin inflammation and tumour susceptibility
- Keratin K15 as a Biomarker of Epidermal Stem Cells
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Physiological and biological skin changes in pregnancy
- Anti-androgenic activities of Ganoderma lucidum
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- How to diagnose a lipodystrophy syndrome
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- The pathophysiology of delayed ejaculation